beijingwalker
ELITE MEMBER
- Joined
- Nov 4, 2011
- Messages
- 65,195
- Reaction score
- -55
- Country
- Location
Back to Normal? COVID Could Kill Another 200,000 If US Congress Doesn't Act
BY FRED GUTERLON 04/06/22 AT 5:00 AM EDT
everywhere you look, people are coming out from under their pandemic rocks. The masks are off, the bars are crowded, the kids are back in school. Even New York City, home to some of the most stringent mandates, no longer requires proof of vaccination in restaurants or masks in schools. On April 7, the Red Sox and the Yankees will square off on Opening Day in front of a potential crowd of 50,000-plus fans eager to cheer full-throated and (mostly) maskless into the breeze.
Baseball fans aren't the only ones yearning to put the pandemic behind them. So, apparently, is Congress. New spending on testing, vaccines and therapeutics has been harder to find than Putin's conscience. Senator Mitt Romney led the charge to whittle White House requests from $30 billion down to $16 billion before settling this week on $10 billion, to be repurposed from unspent COVID-19 relief funds. "While we have supported historic, bipartisan measures in the United States Senate to provide unprecedented investments in vaccines, therapeutics, and testing," he wrote in a letter to President Joe Biden, "it is not yet clear why additional funding is needed." (Emphasis added.)
While Congress fiddles, SARS-CoV-2, the virus that has killed more than a million Americans and as many as 18 million people worldwide so far, according to one estimate, is still at large. Europe's relaxation of pandemic restrictions, together with a more contagious variant of Omicron, BA.2, has triggered a rise in cases and an uptick in the U.S. is expected over the next few weeks. It isn't expected to cause a rise in hospitalizations and deaths in the U.S., but that's not certain.
Beyond the variant du jour are more fraught questions: Does the coronavirus have more surprises in store in the months ahead? Will a new variant come along that evades the protection of vaccines and prior infections and sends this weary nation back into the pandemic doldrums? Scientists have no answers.
Last month, while Russia's invasion of Ukraine dominated the news, a committee of two dozen or so scientists, doctors and public health experts released a report that lays out possible scenarios for the next 12 months. If the coronavirus winds up staying mild and doesn't get much more contagious, deaths may be as low as 15,000 to 30,000. If we're unlucky, a deadly new variant that can evade immune protections could raise the death toll significantly—in this scenario, the group projects casualties of 100,000 to 300,000 lives in the next 12 months.
The wide range in casualties for the worst-case scenario roughly corresponds to how well the nation handles another outbreak, says Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota and a contributor to the report. The fate of 200,000 lives could hang on whether the U.S. has a well-funded plan in place, with enough tests, antiviral medications and vaccines for all, or succumbs to the politics of fatigue and pretends the pandemic is over.
"It's very clear that any investment we make right now in terms of improving our ability to respond to this virus will save us a lot later," says Osterholm. "The more we invest, the lower the number of deaths will be. There's no question about that."
Which way the virus goes—whether it fades away or returns with a vengeance—is uncertain. It's clear, though, that assuming the rosiest scenario without planning for the worst is foolhardy. That is especially true in light of our history with this coronavirus, which turned more deadly in the Delta surge last summer and more transmissible when Omicron hit in January. "Anyone who has any experience with infectious diseases would have to tell you, 'don't bet against this virus,'" says Osterholm.
The longer-term worry is that the nation will forget the miserable performance of its public health system in the last two traumatic years and acquiesce to the status quo. What's needed is a public health overhaul that brings the U.S. up to the level of other advanced nations. Such an overhaul would act as an insurance policy against not just the COVID-19 pandemic but against other biological threats as well—both infectious diseases that emerge from the wild and potential lab-made pathogens intended as weapons, a threat that has grown more likely in recent years by startling advances in low-cost methods of genetic manipulation.
The price tag of such an overhaul would be far steeper than the few billion dollars Congress and the White House have been fighting over. It would cost an initial outlay of $100 billion in public health infrastructure spending, according to the report, and then $20 billion or so a year to maintain readiness.
If $100 billion sounds like a lot of money, it's chicken feed compared to the cost of doing nothing.
Back to Normal? COVID Could Kill Another 200,000 If Congress Doesn't Act
What's needed is a $100-billion public-health overhaul to avoid the next catastrophe.
www.newsweek.com